Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Inclusion Criteria: * diagnosis of non-infectious intermediate, posterior or pan-uveitis Exclusion Criteria: * any ocular trauma within the past 6 months in the study eye * any injection of intraocular corticosteroids or steroid implant or the Ozurdex® implant in the 6 months prior to the study treatment, or any prior use of Retisert™ in the study eye * any uncontrolled systemic disease that would preclude participation in the study or put the subject at risk due to study treatment or procedures * have a known HIV infection or other immunodeficiency disease for which corticosteroid therapy would be contraindicated * are monocular * have ocular hypertension * history of any intraocular surgery in the study eye * presence of an anterior staphyloma in the study eye